Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Press Releases
Donate Now
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

 From
To
  • Default content image

    The Michael J. Fox Foundation Launches 2025 "Parkinson's IQ + You" National Event Series Across the United States to Educate and Empower People and Families Living with Parkinson's Disease

    · Since the series began in 2019, the free events have been designed to empower people with Parkinson’s and care partners to better manage the disease, learn about research participation and connect…
    Learn more Save for later
  • Default content image

    Michael J. Fox Honored with Presidential Medal of Freedom

    Nation’s highest civilian honor recognizes his tireless advocacy and dedication to speeding a cure for Parkinson’s disease NEW YORK (January 4, 2024) — Michael J. Fox, the actor, author, advocate…
    Learn more Save for later
  • Default content image

    The Michael J. Fox Foundation for Parkinson's Research Honors Claudio Soto, PhD, with the Robert A. Pritzker Prize for Leadership in Parkinson's Research

    NEW YORK (November 19, 2024) — The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2024 Robert A. Pritzker Prize for Leadership in Parkinson’s Research to Claudio Soto, PhD,…
    Learn more Save for later
  • Default content image

    The Michael J. Fox Foundation Launches Initiative to Expedite Development of LRRK2-targeted Therapies and Biomarkers for Parkinson’s Disease

    LRRK2 Investigative Therapeutics Exchange (LITE) will support new approaches targeting LRRK2, the most common cause of inherited PD  Program to focus on bridging basic science advances into…
    Learn more Save for later
  • Default content image

    Open-Ocean Row Raises a Record-Breaking $41 Million to Speed Parkinson's Research

    “Team Human Powered Potential’s” open-ocean row, completed on July 19, has raised $41 million for The Michael J. Fox Foundation’s strategic research agenda toward better treatments and a cure for…
    Learn more Save for later
  • Default content image

    FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker, αSyn-SAA, in Clinical Trials in Parkinson’s and Related Diseases

    U.S. regulatory agency recognizes potential of alpha-synuclein seed amplification assay (αSyn-SAA) to accelerate clear outcomes in drugmakers’ trials following multi-stakeholder collaboration…
    Learn more Save for later
  • Default content image

    Rowers Complete Record-breaking 2,800-mile Open Ocean Row to Benefit Michael J. Fox Foundation, Increase Fundraising Goal to $41 Million

    “Team Human Powered Potential” blows through original $28 million fundraising goal With the original milestone completed, and thanks to the continued generosity of an anonymous donor, an increased…
    Learn more Save for later
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.